Publications by authors named "Susanne Maidl"

Article Synopsis
  • Schizophrenia is a complex psychiatric disorder influenced by multiple genetic factors, and recent studies suggest that these genetic variations affect common molecular mechanisms within the brain.
  • By using induced pluripotent stem cells from individuals with varying genetic risks, researchers found significant differences in alternative polyadenylation (APA) of synaptic genes, which correlated with reduced synaptic density.
  • The study identified the RNA binding protein PTBP2 as a key factor influencing these changes in gene expression, highlighting a potential molecular pathway that connects genetic risk to synaptic dysfunction in schizophrenia.
View Article and Find Full Text PDF

Schizophrenia (SCZ) is a highly heritable mental disorder with thousands of associated genetic variants located mostly in the noncoding space of the genome. Translating these associations into insights regarding the underlying pathomechanisms has been challenging because the causal variants, their mechanisms of action, and their target genes remain largely unknown. We implemented a massively parallel variant annotation pipeline (MVAP) to perform SCZ variant-to-function mapping at scale in disease-relevant neural cell types.

View Article and Find Full Text PDF

Angiotensin-converting enzyme 2 (ACE2) is the central entry receptor for SARS-CoV-2. However, surprisingly little is known about the effects of host regulators on ACE2 localization, expression, and the associated influence on SARS-CoV-2 infection. Here we identify that ACE2 expression levels are regulated by the E3 ligase MDM2 and that MDM2 levels indirectly influence infection with SARS-CoV-2.

View Article and Find Full Text PDF

Schizophrenia (SCZ) is a highly polygenic disease and genome wide association studies have identified thousands of genetic variants that are statistically associated with this psychiatric disorder. However, our ability to translate these associations into insights on the disease mechanisms has been challenging since the causal genetic variants, their molecular function and their target genes remain largely unknown. In order to address these questions, we established a functional genomics pipeline in combination with induced pluripotent stem cell technology to functionally characterize ~35,000 non-coding genetic variants associated with schizophrenia along with their target genes.

View Article and Find Full Text PDF

The somatic DNA methylation (DNAme) landscape is established early in development but remains highly dynamic within focal regions that overlap with gene regulatory elements. The significance of these dynamic changes, particularly in the central nervous system, remains unresolved. Here, we utilize a powerful human embryonic stem cell differentiation model for the generation of motor neurons (MNs) in combination with genetic mutations in the de novo DNAme machinery.

View Article and Find Full Text PDF